White matter hyperintensities, cognitive impairment and dementia: An update

Nature Reviews Neurology

Volumn 11, Issue 3, 2015, Pages 157-165

  Prins, Niels D ^a   Scheltens, Philip ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; MEMANTINE;

BRAIN ATROPHY; BRAIN REGION; BRAIN SIZE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; DIFFUSION TENSOR IMAGING; EXERCISE; HUMAN; INCIDENCE; MENTAL PERFORMANCE; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NEUROIMAGING; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; WHITE MATTER HYPERINTENSITY; WHITE MATTER LESION; BRAIN; COMPLICATION; LEUKOENCEPHALOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

BRAIN; COGNITION DISORDERS; DEMENTIA; HUMANS; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING;

EID: 84924650926     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2015.10     Document Type: Review

References (127)

1. Longstreth, W. T. Jr, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 27, 1274-1282 (1996
2. van Dijk, E. J., Prins, N. D., Vermeer, S. E., Koudstaal, P. J. & Breteler, M. M. Frequency of white matter lesions and silent lacunar infarcts. J Neural Transm. Suppl 62, 25-39 (2002
3. de Leeuw, F. E., de Groot, J. C. & van Gijn, J. Cerebral white matter lesions in the elderly: vascular risk factors and cognitive consequences [Dutch]. Ned. Tijdschr. Geneeskd. 145, 2067-2071 (2001
4. Pantoni, L. & Garcia, J. H. Pathogenesis of leukoaraiosis: a review. Stroke 28, 652-659 (1997
5. Brickman, A. M., et al. Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence. Neurobiol. Aging 36, 27-32 (2015
6. Debette, S. & Markus, H. S. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-Analysis. BMJ 341, c3666 (2010
7. Prins, N. D., et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 128, 2034-2041 (2005
8. Vermeer, S. E., et al. Silent brain infarcts and the risk of dementia and cognitive decline. N. Engl. J. Med. 348, 1215-1222 (2003
9. Gorelick, P. B., et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 2672-2713 (2011
10. Pantoni, L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 9, 689-701 (2010
11. Chui, H. C. Subcortical ischemic vascular dementia. Neurol. Clin. 25, 717-740 (2007
12. Lorius, N., et al. Vascular disease and risk factors are associated with cognitive decline in the Alzheimer disease spectrum. Alzheimer Dis. Assoc. Disord. http://dx.doi.org/10.1097/WAD.0000000000000043
13. O'Brien, J. T. & Markus, H. S. Vascular risk factors and Alzheimer's disease. BMC Med. 12, 218 (2014
14. Kalaria, R. N. & Ihara, M. Dementia: vascular and neurodegenerative pathways-will they meet?. Nat. Rev. Neurol. 9, 487-488 (2013
15. Akinyemi, R. O., Mukaetova-Ladinska, E. B., Attems, J., Ihara, M. & Kalaria, R. N. Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer's disease and vascular dementia. Curr. Alzheimer Res. 10, 642-653 (2013
16. Biesbroek, J. M., et al. Association between subcortical vascular lesion location and cognition: a voxel-based and tract-based lesion-symptom mapping study. The SMART-MR study. PLoS ONE 8, e60541 (2013
17. Yoshita, M., et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology 67, 2192-2198 (2006
18. Swartz, R. H., Sahlas, D. J. & Black, S. E. Strategic involvement of cholinergic pathways and executive dysfunction: does location of white matter signal hyperintensities matter?. J. Stroke Cerebrovasc. Dis. 12, 29-36 (2003
19. Fazekas, F., Chawluk, J. B., Alavi, A., Hurtig, H. I. & Zimmerman, R. A. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am. J. Roentgenol. 149, 351-356 (1987
20. Scheltens, P., et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J. Neurol. Sci. 114, 7-12 (1993
21. Gouw, A. A., et al. Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study. J. Neurol. 253, 1189-1196 (2006
22. Maillard, P., et al. An automated procedure for the assessment of white matter hyperintensities by multispectral (T1, T2, PD) MRI and an evaluation of its between-centre reproducibility based on two large community databases. Neuroradiology 50, 31-42 (2008
23. Maldjian, J. A., et al. Automated white matter total lesion volume segmentation in diabetes. AJNR Am. J. Neuroradiol. 34, 2265-2270 (2013
24. Zhang, Y., et al. MRI markers for mild cognitive impairment: comparisons between white matter integrity and gray matter volume measurements. PLoS ONE 8, e66367 (2013
25. Lockhart, S. N., et al. Episodic memory function is associated with multiple measures of white matter integrity in cognitive aging. Front. Hum. Neurosci. 6, 56 (2012
26. Verhaaren, B. F., et al. High blood pressure and cerebral white matter lesion progression in the general population. Hypertension 61, 1354-1359 (2013
27. Schmidt, R., et al. White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations. Stroke 43, 2643-2647 (2012
28. van Dijk, E. J., et al. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 39, 2712-2719 (2008
29. Pantoni, L. & Simoni, M. Pathophysiology of cerebral small vessels in vascular cognitive impairment. Int. Psychogeriatr. 15 (Suppl 1), 59-65 (2003
30. Román, G. C., Erkinjuntti, T., Wallin, A., Pantoni, L. & Chui, H. C. Subcortical ischaemic vascular dementia. Lancet Neurol. 1, 426-436 (2002
31. De Groot, J. C., et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann. Neurol. 52, 335-341 (2002
32. Garde, E., Lykke Mortensen, E., Rostrup, E. & Paulson, O. B. Decline in intelligence is associated with progression in white matter hyperintensity volume. J. Neurol. Neurosurg. Psychiatry 76, 1289-1291 (2005
33. Swan, G. E., et al. Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy. Neurology 54, 2108-2114 (2000
34. Snowdon, D. A., et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277, 813-817 (1997
35. Neuropathology Group. Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 357, 169-175 (2001
36. Hachinski, V. C., Potter, P. & Merskey, H. Leuko-Araiosis. Arch. Neurol. 44, 21-23 (1987
37. Wahlund, L. O., et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32, 1318-1322 (2001
38. Fazekas, G., et al. Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment. J. Neurol. Sci. 134, 83-38 (1995
39. Kapeller, P., et al. Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke 34, 441-445 (2003
40. Prins, N. D., et al. Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology 62, 1533-1539 (2004
41. Wu, M., et al. A fully automated method for quantifying and localizing white matter hyperintensities on MR images. Psychiatry Res. 148, 133-142 (2006
42. Gouw, A. A., et al. Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovasc. Dis. 25, 247-253 (2008
43. Schwarz, C., Fletcher, E., DeCarli, C. & Carmichael, O. Fully-Automated white matter hyperintensity detection with anatomical prior knowledge and without FLAIR. Inf. Process. Med. Imaging 21, 239-251 (2009
44. Maillard, P., et al. FLAIR and diffusion MRI signals are independent predictors of white matter hyperintensities. AJNR Am. J. Neuroradiol. 34, 54-61 (2013
45. Papma, J. M., et al. Cerebral small vessel disease affects white matter microstructure in mild cognitive impairment. Hum. Brain Mapp. 35, 2836-2851 (2014
46. Yates, P. A., et al. Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations. Front. Neurol. 4, 205 (2014
47. Lee, S. H., et al. Dynamic temporal change of cerebral microbleeds: long-Term follow-up MRI study. PLoS ONE 6, e25930 (2011
48. Yates, P. A., et al. Incidence of cerebral microbleeds in preclinical Alzheimer disease. Neurology 82, 1266-1273 (2014
49. Smith, E. E., Schneider, J. A., Wardlaw, J. M. & Greenberg, S. M. Cerebral microinfarcts: the invisible lesions. Lancet Neurol. 11, 272-282 (2012
50. Koennecke, H. C. Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology 66, 165-171 (2006
51. Simoni, M., et al. Age- And sex-specific rates of leukoaraiosis in TIA and stroke patients: population-based study. Neurology 79, 1215-1222 (2012
52. Ylikoski, A., et al. White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 26, 1171-1177 (1995
53. Schmidt, R., et al. Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 53, 687-692 (2004
54. de Leeuw, F. E., et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J. Neurol. Neurosurg. Psychiatry 70, 9-14 (2001
55. Barber, R., et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J. Neurol. Neurosurg. Psychiatry 67, 66-72 (1999
56. Lee, S. J., et al. The leukoaraiosis is more prevalent in the large artery atherosclerosis stroke subtype among Korean patients with ischemic stroke. BMC Neurol. 8, 31 (2008
57. Pantoni, L., et al. Impact of age-related cerebral white matter changes on the transition to disability-The LADIS study: rationale, design and methodology. Neuroepidemiology 24, 51-62 (2005
58. Schmidt, R., et al. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann. Neurol. 58, 610-616 (2005
59. Pantoni, L. & Garcia, J. H. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke 26, 1293-1301 (1995
60. Gouw, A. A., et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J. Neurol. Neurosurg. Psychiatry 82, 126-135 (2011
61. de Leeuw, F. E., et al. Aortic atherosclerosis at middle age predicts cerebral white matter lesions in the elderly. Stroke 31, 425-429 (2000
62. de Leeuw, F. E., et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 125, 765-772 (2002
63. Goldstein, I. B., Bartzokis, G., Guthrie, D. & Shapiro, D. Ambulatory blood pressure and the brain: a 5 year follow-up. Neurology 64, 1846-1852 (2005
64. Gottesman, R. F., et al. Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study. Stroke 41, 3-8 (2010
65. Brundel, M., Kappelle, L. J. & Biessels, G. J. Brain imaging in type 2 diabetes. Eur. Neuropsychopharmacol. 24, 1967-1981 (2014
66. Tiehuis, A. M., et al. Metabolic syndrome, prediabetes, and brain abnormalities on MRI in patients with manifest arterial disease: the SMART-MR study. Diabetes Care 37, 2515-2521 (2014
67. Exalto, L. G., van der Flier, W. M., Scheltens, P., Vrenken, H. & Biessels, G. J. Dysglycemia, brain volume and vascular lesions on MRI in a memory clinic population. J. Diabetes Complications 28, 85-90 (2014
68. Knopman, D. S., et al. Vascular risk factors and longitudinal changes on brain MRI: the ARIC study. Neurology 76, 1879-1885 (2011
69. van Dijk, E. J., et al. Plasma amyloid β, apolipoprotein E, lacunar infarcts, and white matter lesions. Ann. Neurol. 55, 570-575 (2004
70. Vinters, H. V., Secor, D. L., Pardridge, W. M. & Gray, F. Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy. Ann. Neurol. 28, 34-42 (1990
71. Moody, D. M., Brown, W. R., Challa, V. R. & Anderson, R. L. Periventricular venous collagenosis: association with leukoaraiosis. Radiology 194, 469-476 (1995
72. Englund, E. Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. Dement. Geriatr. Cogn. Disord. 9 (Suppl 1), 6-12 (1998
73. Richardson, K., et al. The neuropathology of vascular disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Curr. Alzheimer Res. 9, 687-696 (2012
74. Nicoll, J. A., et al. Association between APOE genotype, neuropathology and dementia in the older population of England and Wales. Neuropathol. Appl. Neurobiol. 37, 285-294 (2011
75. Noh, Y., et al. White matter hyperintensities are associated with amyloid burden in APOE4 non-carriers. J. Alzheimers Dis. 40, 877-886 (2014
76. Chao, L. L., et al. Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI. PLoS ONE 8, e65175 (2013
77. Kim, H. J., et al. The effects of small vessel disease and amyloid burden on neuropsychiatric symptoms: a study among patients with subcortical vascular cognitive impairments. Neurobiol. Aging 34, 1913-1920 (2013
78. Barnes, J., et al. Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls. Neurobiol. Aging 34, 1996-2002 (2013
79. Guzman, V. A., et al. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment. Alzheimers Dement. 9 (5 Suppl.), S124-S131 (2013
80. Chabriat, H., et al. Patterns of MRI lesions in CADASIL. Neurology 51, 452-457 (1998
81. Tikka, S., et al. CADASIL and CARASIL. Brain Pathol. 24, 525-544 (2014
82. Bianchi, S., et al. Two novel HTRA1 mutations in a European CARASIL patient. Neurology 82, 898-900 (2014
83. Bersano, A., et al. The genetics of small-vessel diseasE curr. Med. Chem. 19, 4124-4141 (2012
84. Fornage, M., et al. Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann. Neurol. 69, 928-939 (2011
85. Adib-Samii, P., et al. 17q25 locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status. Stroke 44, 1609-1615 (2013
86. Tabara, Y., et al. Association of Chr17q25 with cerebral white matter hyperintensities and cognitive impairment: the J SHIPP study. Eur. J. Neurol. 20, 860-862 (2013
87. Viswanathan, A. & Greenberg, S. M. Cerebral amyloid angiopathy in the elderly. Ann. Neurol. 70, 871-880 (2011
88. Vinters, H. V., et al. Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA D). Acta Neuropathol. 95, 235-244 (1998
89. McDonald, W. I., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50, 121-127 (2001
90. van der Knaap, M. S., Breiter, S. N., Naidu, S., Hart, A. A. & Valk, J. Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology 213, 121-133 (1999
91. Yoshida, T., et al. MELAS and reversible vasoconstriction of the major cerebral arteries. Intern. Med. 52, 1389-1392 (2013
92. de Groot, J. C., et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann. Neurol. 47, 145-151 (2000
93. Kramer, J. H., Reed, B. R., Mungas, D., Weiner, M. W. & Chui, H. C. Executive dysfunction in subcortical ischaemic vascular disease. J. Neurol. Neurosurg. Psychiatry 72, 217-220 (2002
94. Mungas, D., et al. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology 57, 2229-2235 (2001
95. Carmichael, O., et al. Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch. Neurol. 67, 1370-1378 (2010
96. Longstreth, W. T., Diehr, P. H., Yee, L. M., Newman, A. B. & Beauchamp, N. J. Brain imaging findings in elderly adults and years of life, healthy life, and able life over the ensuing 16 years: the Cardiovascular Health Study. J. Am. Geriatr. Soc. 62, 1838-1843 (2014
97. LADIS Study Group. 2001-2011: a decade of the LADIS (Leukoaraiosis And DISability) Study: what have we learned about white matter changes and small-vessel disease?. Cerebrovasc. Dis. 32, 577-588 (2011
98. Prins, N. D., et al. Cerebral white matter lesions and the risk of dementia. Arch. Neurol. 61, 1531-1534 (2004
99. Román, G. C. & Kalaria, R. N. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol. Aging 27, 1769-1785 (2006
100. Kimura, S., et al. Pathogenesis of vascular dementia in stroke-prone spontaneously hypertensive rats. Toxicology 153, 167-178 (2000
101. Strachan, M. W., Reynolds, R. M., Marioni, R. E. & Price, J. F. Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat. Rev. Endocrinol. 7, 108-114 (2011
102. Sachdev, P. S., et al. Homocysteine as a risk factor for cognitive impairment in stroke patients. Dement. Geriatr. Cogn. Disord. 15, 155-162 (2003
103. Breteler, M. M. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol. Aging 21, 153-160 (2000
104. Kalaria, R. N. Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc. Dis. 13 (Suppl 2), 48-52 (2002
105. Hainsworth, A. H., Brittain, J. F. & Khatun, H. Pre-clinical models of human cerebral small vessel disease: utility for clinical application. J. Neurol. Sci. 322, 237-240 (2012
106. Bink, D. I., Ritz, K., Aronica, E., van der Weerd, L. & Daemen, M. J. Mouse models to study the effect of cardiovascular risk factors on brain structure and cognition. J. Cereb. Blood Flow Metab. 33, 1666-1684 (2013
107. van der Flier, W. M., et al. Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study. J. Neurol. Neurosurg. Psychiatry 76, 1497-1500 (2005
108. Jang, J. W., et al. Effect of white matter hyperintensity on medial temporal lobe atrophy in Alzheimer's disease. Eur. Neurol. 69, 229-235 (2013
109. Erkinjuntti, T., et al. Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease?. J. Neurol. Neurosurg. Psychiatry 50, 37-42 (1987
110. Price, C. C., Jefferson, A. L., Merino, J. G., Heilman, K. M. & Libon, D. J. Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data. Neurology 65, 376-382 (2005
111. DeCarli, C., et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 45, 2077-2084 (1995
112. Brickman, A. M., et al. White matter hyperintensities and cognition: testing the reserve hypothesis. Neurobiol. Aging 32, 1588-1598 (2011
113. Murray, A. D., et al. The balance between cognitive reserve and brain imaging biomarkers of cerebrovascular and Alzheimer's diseases. Brain 134, 3687-3696 (2011
114. Skoog, I., Kalaria, R. N. & Breteler, M. M. Vascular factors and Alzheimer disease. Alzheimer Dis. Assoc. Disord. 13 (Suppl 3), S106-S114 (1999
115. Forette, F., et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352, 1347-1351 (1998
116. Williamson, J. D., et al. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. JAMA Intern. Med. 174, 324-333 (2014
117. ten Dam, V. H., et al. Effect of pravastatin on cerebral infarcts and white matter lesions. Neurology 64, 1807-1809 (2005
118. Richard, E., Gouw, A. A., Scheltens, P. & van Gool, W. A. Vascular care in patients with Alzheimer disease with cerebrovascular lesions slows progression of white matter lesions on MRI: the evaluation of vascular care in Alzheimer's disease (EVA) study. Stroke 41, 554-556 (2010
119. Richard, E., Kuiper, R., Dijkgraaf, M. G., Van Gool, W. A. & Evaluation of Vascular care in Alzheimer's disease. Vascular care in patients with Alzheimer's disease with cerebrovascular lesions-A randomized clinical trial. J. Am. Geriatr. Soc. 57, 797-805 (2009
120. Richard, E., et al. Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress. Alzheimer Dis. Assoc. Disord. 23, 198-204 (2009
121. Cyarto, E. V., et al. Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trial. BMC Psychiatry 12, 167 (2012
122. Román, G. C., et al. Donepezil in vascular dementia: combined analysis of two large-scale clinical trials. Dement. Geriatr. Cogn. Disord. 20, 338-344 (2005
123. Wilkinson, D., et al. The long-Term efficacy and tolerability of donepezil in patients with vascular dementia. Int. J. Geriatr. Psychiatry 25, 305-313 (2010
124. Erkinjuntti, T., et al. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 359, 1283-1290 (2002
125. Orgogozo, J. M., Rigaud, A. S., Stöffler, A., Möbius, H. J. & Forette, F. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke 33, 1834-1839 (2002
126. Inzitari, D., et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ 339, b2477 (2009
127. de Leeuw, F. E., Barkhof, F. & Scheltens, P. Progression of cerebral white matter lesions in Alzheimer's disease: a new window for therapy?. J. Neurol. Neurosurg. Psychiatry 76, 1286-1288 (2005